Andrew K Chan - Net Worth and Insider Trading

Andrew K Chan Net Worth

The estimated net worth of Andrew K Chan is at least $3 Million dollars as of 2024-09-25. Andrew K Chan is the SVP Corp Bus Dev and Secretary of Cellular Biomedicine Group Inc and owns about 154,090 shares of Cellular Biomedicine Group Inc (CBMG) stock worth over $3 Million. Details can be seen in Andrew K Chan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew K Chan has not made any transactions after 2017-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew K Chan

To

Andrew K Chan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew K Chan owns 1 companies in total, including Cellular Biomedicine Group Inc (CBMG) .

Click here to see the complete history of Andrew K Chan’s form 4 insider trades.

Insider Ownership Summary of Andrew K Chan

Ticker Comapny Transaction Date Type of Owner
CBMG Cellular Biomedicine Group Inc 2019-12-31 Ch Legal Ofr & Corp Dev & Sec

Andrew K Chan Latest Holdings Summary

Andrew K Chan currently owns a total of 1 stock. Andrew K Chan owns 154,090 shares of Cellular Biomedicine Group Inc (CBMG) as of December 22, 2017, with a value of $3 Million.

Latest Holdings of Andrew K Chan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CBMG Cellular Biomedicine Group Inc 2017-12-22 154,090 19.75 3,043,278

Holding Weightings of Andrew K Chan


Andrew K Chan Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew K Chan has made a total of 0 transactions in Cellular Biomedicine Group Inc (CBMG) over the past 5 years. The most-recent trade in Cellular Biomedicine Group Inc is the acquisition of 8,333 shares on December 22, 2017, which cost Andrew K Chan around $99,996.

Insider Trading History of Andrew K Chan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew K Chan Trading Performance

GuruFocus tracks the stock performance after each of Andrew K Chan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew K Chan is 77.93%. GuruFocus also compares Andrew K Chan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew K Chan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andrew K Chan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andrew K Chan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 68.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 63.34 LIMIT LIMIT LIMIT LIMIT LIMIT

Andrew K Chan Ownership Network

Ownership Network List of Andrew K Chan

No Data

Ownership Network Relation of Andrew K Chan

Insider Network Chart

Andrew K Chan Owned Company Details

What does Cellular Biomedicine Group Inc do?

Who are the key executives at Cellular Biomedicine Group Inc?

Andrew K Chan is the Ch Legal Ofr & Corp Dev & Sec of Cellular Biomedicine Group Inc. Other key executives at Cellular Biomedicine Group Inc include 10 percent owner Ag Novartis , 10 percent owner Pharma Ag Novartis , and 10 percent owner Maplebrook Ltd .

Cellular Biomedicine Group Inc (CBMG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cellular Biomedicine Group Inc (CBMG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellular Biomedicine Group Inc (CBMG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cellular Biomedicine Group Inc (CBMG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cellular Biomedicine Group Inc Insider Transactions

No Available Data

Andrew K Chan Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew K Chan. You might contact Andrew K Chan via mailing address: 530 University Avenue, #17 Palo Alto Ca 94301.

Discussions on Andrew K Chan

No discussions yet.